Venous Thrombolysis Mantis

Traditional treatment of venous thrombolysis is oral anticoagulation following anticoagulation with heparin. Anticoagulant therapy effectively inhibits the dissemination and embolization of the clot, but does not dissolve the clot mass. The absence of thrombolytic effect in the majority of patients treated with classical treatment; Posttrombotic syndrome (PTS) develops because of the failure of venous valve function and the development of venous hypertension.

 

Since thrombolytic therapy dissolves the formed clot in the early stage, it is possible to protect the valve function and prevent the PTS. For this reason, thrombolytic therapy has been used in many centers for a long time. Despite the widespread acceptance of the effectiveness of systemic thrombolytic therapy from the vascular route to the entire body, its use in many centers has been discontinued due to the potential for catastrophic bleeding and uncertainties in the dosage and administration.

 

Thanks to the developments in modern medicine and catheter methods, it can be prevented to go into the clot in the early period, to ensure active clot dissolution and to cure the patients before the valve destruction develops.

 

These methods are catheter-like thrombolytic therapy with catheters called catheter-like thrombolytic therapy or clogged thrombus called catheters. Angioplasty and stent implantation may be required for residual stenosis after active flushing of the clot in the vein.

 

This product, called the deep vein thrombosis device Mantis, has many advantages for patients.

The battery-powered battery initiates a mechanical rotation of a unique cross-sectional shape with aspirated venous thrombolysis pharmaco-mechanical deformation and controlled and selective infusion of the fluids indicated by the physician, including peripheral vascular thrombolytic; Double engine volume, low and high speed options and hydrophilic inserts are available.

 

The battery powered hand drive initiates the mechanical rotation of the atraumatic unique cycle shape by aspiration.

 

It protects the vessel wall with its leaf-shaped end design. It also creates vortex effect to prevent distal emboli and thrombus by TPA. The internal infusion port provides TPA and contrast infusion. The tip diameter of the tip diameter can be adjusted from 5 to 20 mm in diameter. Depending on the area of ​​application and vessel size, the physician provides treatment. Significantly reduces the dose of thrombolytic therapy. It significantly prevents post-thrombolytic syndrome and most importantly provides a significant advantage for the patient by reducing hospitalization.



Leave a Reply